sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Files Disclosure on Mural Oncology plc
The Vanguard Group, Inc. has publicly disclosed its position in Mural Oncology plc pursuant to Rule 8.3 of the Irish Takeover Panel Act, 1997. This disclosure pertains to interests in securities representing 1% or more in the company. As of November 12, 2025, Vanguard holds a 1.67% interest, equivalent to 288,731 ordinary shares at $0.01 each.
Recently, a purchase of 16 shares at a price of 2.08 USD per share was noted. There are no cash-settled or stock-settled derivatives or related agreements. Additionally, no collateral arrangements or commitments are linked to this disclosure.
There is no supplementary Form 8 attached to this disclosure. Details on voting rights or further acquisitions linked to derivatives were also absent.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.